PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three months ended March 31, 2010. Highlights of the first quarter of 2010 and subsequent weeks include:
